All 76 IDNA (ISHARES GENOMICS IMMUNOLOGY AND HEALTHCARE ETF) Holdings
There are 76 IDNA holdings. Top 10 companies weight: 47.17%.
Total Market Cap: $626B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (76 stocks) | +10.53% | 23.13 | 18.02 | 3.16 | +24.71% | +9.10% | 0.58 | ||||||||||
1 | RVMD | Revolution Medicines Inc Ordinary Shares | 7.00% | $151.31 | $31B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +22.61% | $186 | +38.07% | 1.07 |
2 | MRNA | Moderna Inc | 6.44% | $45.64 | $19B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 48 | -5.35% | $43 | -25.22% | 1.37 |
3 | n/a | Ipsen Sa | 5.17% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
4 | n/a | Takeda Pharmaceutical Co Ltd | 4.43% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
5 | MRK | Merck & Co Inc | 4.27% | $115.70 | $297B | Drug Manufacturers - General | Healthcare | +4.39% | 27.45 | 22.78 | 5.59 | N/A | N/A | 69 | +12.13% | $130 | +12.86% | 0.32 |
6 | n/a | Bayer Ag | 4.25% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
7 | n/a | Gsk Plc | 4.03% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
8 | n/a | Roche Holding Ag Ordinary Shares New | 3.94% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
9 | BNTX | Biontech Se Adr | 3.89% | $89.14 | $24B | Biotechnology | Healthcare | N/A | N/A | 7.04 | N/A | N/A | N/A | 69 | +39.17% | $124 | -15.79% | 0.95 |
10 | EXEL | Exelixis Inc | 3.75% | $48.54 | $13B | Biotechnology | Healthcare | +72.24% | 15.79 | 15.92 | 0.41 | N/A | N/A | 61 | +2.29% | $50 | +16.95% | 0.55 |
11 | REGN | Regeneron Pharmaceuticals Inc | 3.72% | $602.92 | $65B | Biotechnology | Healthcare | +20.31% | 14.98 | 13.39 | 83.17 | N/A | N/A | 72 | +38.21% | $833 | +3.75% | 0.64 |
12 | TWST | Twist Bioscience Corp | 3.62% | $70.15 | $3.99B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 75 | -8.14% | $64 | -6.10% | 2.04 |
13 | INCY | Incyte Corp | 3.57% | $92.24 | $20B | Biotechnology | Healthcare | +27.16% | 13.38 | 12.41 | N/A | N/A | N/A | 58 | +17.04% | $108 | +2.16% | 0.62 |
14 | VRTX | Vertex Pharmaceuticals Inc | 3.56% | $425.09 | $111B | Biotechnology | Healthcare | +9.89% | 25.66 | 23.04 | 1.64 | N/A | N/A | 74 | +29.08% | $549 | +15.02% | 0.51 |
15 | n/a | Sanofi Sa | 3.28% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
16 | n/a | Genmab As | 3.18% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
17 | IBRX | Immunitybio Inc Ordinary Shares | 2.72% | $7.23 | $8.26B | Biotechnology | Healthcare | -9.78% | N/A | N/A | N/A | N/A | N/A | 83 | +79.81% | $13 | -16.43% | 1.59 |
18 | IDYA | Ideaya Biosciences Inc | 2.68% | $27.87 | $2.57B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +85.47% | $52 | +6.44% | 1.11 |
19 | CAI | Caris Life Sciences Inc | 2.38% | $16.52 | $4.35B | Biotechnology | Healthcare | N/A | N/A | 43.29 | N/A | N/A | N/A | 73 | +68.46% | $28 | 0.00% | 1.49 |
20 | RCUS | Arcus Biosciences Inc | 2.16% | $24.47 | $3.01B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +42.30% | $35 | -0.26% | 1.50 |
21 | n/a | Ono Pharmaceutical Co Ltd | 1.95% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
22 | CRSP | Crispr Therapeutics Ag | 1.84% | $52.02 | $5.16B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | N/A | N/A | N/A | -13.88% | N/A |
23 | IOVA | Iovance Biotherapeutics Inc | 1.42% | $4.10 | $1.91B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +114.63% | $8.80 | -25.12% | 1.66 |
24 | NVAX | Novavax Inc | 1.32% | $10.21 | $1.82B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +38.20% | $14 | -43.27% | 1.50 |
25 | NUVB | N/A | 1.17% | $4.90 | $1.64B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +151.63% | $12 | -18.26% | 1.49 |
26 | ABCL | Abcellera Biologics Inc Ordinary Shares | 1.17% | $6.13 | $1.65B | Biotechnology | Healthcare | N/A | N/A | 27.55 | N/A | N/A | N/A | 75 | +70.15% | $10 | -24.85% | 1.61 |
27 | n/a | N/A | 1.14% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
28 | VIR | Vir Biotechnology Inc | 1.06% | $8.74 | $1.47B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +135.24% | $21 | -28.26% | 1.58 |
29 | CRVS | Corvus Pharmaceuticals Inc | 1.01% | $11.69 | $1.09B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +34.16% | N/A |
30 | KURA | Kura Oncology Inc | 0.86% | $8.97 | $909M | Biotechnology | Healthcare | +15.40% | N/A | N/A | N/A | N/A | N/A | 76 | +247.49% | $31 | -15.97% | 1.07 |
31 | JANX | Janux Therapeutics Inc Ordinary Shares | 0.86% | $13.78 | $879M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +194.34% | $41 | 0.00% | 1.23 |
32 | n/a | N/A | 0.69% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
33 | OCGN | Ocugen Inc | 0.63% | $1.34 | $467M | Biotechnology | Healthcare | +8.79% | N/A | 13.07 | N/A | N/A | N/A | 78 | +752.99% | $11 | -31.51% | 1.75 |
34 | CTMX | Cytomx Therapeutics Inc | 0.59% | $3.16 | $675M | Biotechnology | Healthcare | N/A | 25.70 | 14.20 | 0.79 | N/A | N/A | 83 | +293.67% | $12 | -14.21% | 2.03 |
35 | RIGL | Rigel Pharmaceuticals Inc | 0.58% | $30.02 | $543M | Biotechnology | Healthcare | N/A | 4.92 | 6.63 | N/A | N/A | N/A | 65 | +77.22% | $53 | -4.61% | 1.16 |
36 | NTLA | Intellia Therapeutics Inc | 0.57% | $13.13 | $1.62B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +102.82% | $27 | -28.75% | 1.70 |
37 | n/a | Abclon Inc | 0.54% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
38 | n/a | Shanghai Henlius Biotech Inc Class H | 0.50% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
39 | DNA | Ginkgo Bioworks Holdings Inc | 0.46% | $9.34 | $538M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 25 | -8.99% | $8.50 | -52.71% | 2.35 |
40 | DSGN | Design Therapeutics Inc | 0.46% | $10.17 | $693M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 83 | +106.49% | $21 | -17.73% | 1.16 |
41 | PACB | Pacific Biosciences Of California Inc | 0.46% | $1.58 | $401M | Medical Devices | Healthcare | +5.07% | N/A | N/A | N/A | N/A | N/A | 56 | +55.57% | $2.46 | -42.65% | 2.02 |
42 | n/a | Usd Cash | 0.45% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
43 | VSTM | Verastem Inc | 0.43% | $3.81 | $373M | Biotechnology | Healthcare | -2.77% | N/A | N/A | N/A | N/A | N/A | 77 | +319.95% | $16 | -39.57% | 1.45 |
44 | n/a | Valneva Se | 0.42% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
45 | ALVO | Alvotech | 0.41% | $3 | $1.14B | Drug Manufacturers - Specialty & Generic | Healthcare | -18.97% | N/A | 7.91 | N/A | N/A | N/A | 62 | +361.00% | $14 | 0.00% | 0.80 |
46 | n/a | Jpy/usd Purchased | 0.36% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
47 | PSNL | Personalis Inc | 0.35% | $11.14 | $994M | Diagnostics & Research | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 75 | -2.51% | $11 | -11.65% | 2.15 |
48 | XNCR | Xencor Inc | 0.34% | $11.21 | $868M | Biotechnology | Healthcare | +10.21% | N/A | 68.03 | N/A | N/A | N/A | 76 | +154.24% | $29 | -21.07% | 1.50 |
49 | n/a | N/A | 0.13% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
50 | PRME | Prime Medicine Inc | 0.12% | $3.21 | $596M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 69 | +115.58% | $6.92 | 0.00% | 2.10 |
IDNA (ISHARES GENOMICS IMMUNOLOGY AND HEALTHCARE ETF) Sector Allocation
HEALTHCARE
62.90%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%